Xtant Medical Holdings (XTNT) Change in Receivables (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Change in Receivables for 16 consecutive years, with -$1.2 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Change in Receivables fell 120.36% year-over-year to -$1.2 million in Q3 2025; TTM through Sep 2025 was $6.3 million, a 244.85% increase from a year earlier, with the FY2024 full-year figure at $755000.0, down 91.36% from the prior year.
• Change in Receivables was -$1.2 million for Q3 2025 at Xtant Medical Holdings, down from $3.8 million in the prior quarter.
• Over five years, Change in Receivables peaked at $3.9 million in Q3 2023 and troughed at -$1.2 million in Q3 2025.
• A 5-year average of $1.0 million and a median of $903000.0 in 2021 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables slumped 215.61% in 2021 and surged 2068.06% in 2025, its largest moves.
• Over 5 years, Change in Receivables stood at $903000.0 in 2021, then climbed by 8.42% to $979000.0 in 2022, then soared by 72.52% to $1.7 million in 2023, then sank by 62.88% to $627000.0 in 2024, then sank by 296.81% to -$1.2 million in 2025.
• The last three Change in Receivables figures came in at -$1.2 million (Q3 2025), $3.8 million (Q2 2025), and $3.1 million (Q1 2025), per Business Quant data.